comparemela.com

Latest Breaking News On - Priya singhal - Page 2 : comparemela.com

Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences

Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-mediated diseasesFelzartamab is an investigational.

Biogen Inc : Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences

Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-mediated diseasesFelzartamab is an investigational

Biogen inks $1 15B HI-Bio buyout to expand in immunology

HI-Bio is preparing to advance an anti-CD38 monoclonal antibody into phase 3 in multiple rare immune-mediated indications.

Biogen acquires Hi-Bio, California biotech, for $1 15 billion

The deal comes as the Cambridge drugmaker seeks to bolster its pipeline of experimental medicines.

Biogen to buy Human Immunology Biosciences in deal worth up to $1 8B

Biogen to buy Human Immunology Biosciences in deal worth up to $1 8B
mmm-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mmm-online.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.